MedTrace Logo

Postoperative Analgesia Following Wisdom Teeth Removal: Ropivacaine Versus Placebo

NCT01541059 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-11-19

No results posted yet for this study

Summary

The main objective of this study is to demonstrate the superiority of local analgesia with ropivacaine versus placebo on postoperative pain during the first 24 hours following bilateral surgery of all four third molars under general anesthesia.

Conditions

  • Third Molar Extraction

Interventions

DRUG

Placebo injection

Injection of saline solution into the vestibular capsule of each tooth to be extracted.

DRUG

Ropivacaine injection

Ropivacaine is injected into the vestibular capsule of each tooth to be extracted.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Jacques Ripart, MD PhD · Centre Hospitalier Universitaire de Nîmes

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2015-08-29
Completion
2015-08-29

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01541059 on ClinicalTrials.gov